Caring for Patients with Endometrial Hyperplasia/Cancer: Exploring the Initial Evaluation/Diagnosis, Surgery, Maintenance/Recurrence Treatment Options, and Survivorship Strategies to Optimize Quality of Life
Caring for Patients with Endometrial Hyperplasia/Cancer: Exploring the Initial Evaluation/Diagnosis, Surgery, Maintenance/Recurrence Treatment Options, and Survivorship Strategies to Optimize Quality of Life
Endometrial cancer is the most common gynecologic cancer in United States and results in significant mobidity and morality. Multiple factors play a role in the effective treatment and management of patients diagnosed with endometrial cancer. There exists a tremendous amount of data which clinicians require to obtain in order to remain abreast of the most effective strategies to treat these processes and optimize quality of life.
This program will discuss the evaluation and management of endometrial hyperplasia and endometrial cancer with a focus on the evolving treatment paradigms for maintenance drugs and the use of immunotherapy/targeted agents in the setting of metastatic or recurrent endometrial cancer. Additionally, this program will profile survivorship challenges such as the optimization of functional recovery of strength after systemic therapies, radical pelvic surgery, and/or radiation, with a focus on UTIs, urinary incontinence, and pelvic organ prolapse after treatment for pelvic pre-cancer and/or cancer.
Target Audience
This educational activity is directed towards family practitioners, internal medicine, gynecology and obstetrics, medical oncologists, radiation oncologists, gynecologic oncologists and other allied heath care providers interested in the topic of endometrial hyperplasia, endometrial cancer, and cancer survivorship.
Learning Objectives
- Outline management strategies for the initial evaluation and diagnosis of endometrial hyperplasia and endometrial cancer.
- Distinguish different management strategies including fertility preservation and surgical approach with sentinel lymph node dissection.
- Examine maintenance and recurrent treatment paradigms for endometrial cancer including targeted agents, immunotherapy, chemotherapy, and radiation.
- Identify and assess pelvic organ prolapse and urinary incontinence in the setting of pelvic cancer treatment.
- Outline survivorship strategies to improve quality of life for patients treated for endometrial cancer.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
EVENT PARKING:
- Free Self Parking
- Discounted Valet Parking: $10
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
DISCLOSURE INFORMATION:
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any ineligible company. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest, and an "ineligible company" as any entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Any potential conflicts relative to the previous disclosure have been resolved.
Written disclosure of all such relevant financial relationships will be provided in the activity handout and/or syllabus. Any potential conflicts relative to the previous disclosure have been resolved.
City of Hope further encourages faculty/authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.
Available Credit
- 1.50 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this Caring for Patients with Endometrial Hyperplasia/Cancer: Exploring the Initial Evaluation/Diagnosis, Surgery, Maintenance/Recurrence Treatment Options, and Survivorship Strategies to Optimize Quality of Life for a maximum of 1.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.50 Attendance
Price
REGISTRATION CLOSED | NO ONSITE REGISTRATIONS ALLOWED
Registrant Type | Registration |
---|---|
Physician (Dinner Included) | $0 |
Nurse/Other Allied Health Care Provider (Dinner Included) | $0 |
Student/Resident/Fellow (Dinner Included) | $0 |
*Industry/Commercial Employee Attendee (Dinner Included) | $300 |
Registration includes meeting, dinner, and CME Credit.
For questions, contact the Department of Continuing Medical Education at cme@coh.org or 626-218-5622
*Industry/Commercial Employee Attendee is defined as any individual employed by a for-profit, including biotech, financial and pharmaceutical.